Nelson, Van Denburg & Campbell Wealth Management Group, LLC Eye Point Pharmaceuticals, Inc. Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.25 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$19.93 - $29.71 $6,297 - $9,388	316 New	316 $6,000
Q2 2021 Jul 27, 2021	SELL	$8.69 - $11.08 $434 - $554	-50 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$8.89 - $14.92 $444 - $746	50 New	50 $0

Others Institutions Holding EYPT

# of Institutions

163

Shares Held

58.2M

Call Options Held

224K

Put Options Held

1.41M

Cormorant Asset Management, LP Boston, MA

8.33M
Shares

$66.4 Million
5.57% of portfolio
Suvretta Capital Management, LLC New York, NY

5.18M
Shares

$41.3 Million
1.88% of portfolio
Black Rock Inc. New York, NY

3.76M
Shares

$30 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

3.65M
Shares

$29.1 Million
0.01% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.59M
Shares

$28.7 Million
0.06% of portfolio

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $272M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account